ECFS Board Elections 2021

Dr. Janet Allen MD, has recently started a position at the University of Cambridge to continue contributing to CF research activity. Janet worked at the UK CF Trust for 8 years initially in charge of Research and finally responsible for Strategic Innovation. She firmly believes that international cooperation is critical for success and that organisations such as the ECFS can play a crucial role to influence thinking and raise the profile of CF.

Nominations
Application
CV

Dr. Ian Balfour-Lynn is a consultant in Paediatric Respiratory Medicine at the Royal Brompton Hospital, London, since 1997. He has been Director of  the Paediatric Cystic Fibrosis Unit, one of the largest in the UK, for over a decade.  Ian has been involved in many ECFS activities and recently started cooperation as a mentor site in an ECFS Standards of Care twinning cooperation.

Nominations
Application
CV

Prof. Jane Davies is a a leading clinician and researcher based at the Royal Brompton Hospital and Imperial College London. She is Professor in pediatric respirology and experimental medicine. She has been involved in various activities and ECFS working groups and the  ECFS CTN for many years. She is leading the ECFS lung clearance index core facility. Recently, she has taken on the role of Deputy Editor of the Journal of Cystic Fibrosis. 

Nominations
Application
CV

Prof. Pavel Drevinek is a well-known figure in the CF community worldwide.
He is Professor in Microbiology at the Motol University, Prague, director of the Czech CF register and principal investigator of different clinical trials. He has been an active member of the ECFS for many years and is supervising the ECFS Standards of Care Twinning project, which helps fostering the partnership between CF centres.

Nominations
Application
CV

Prof. Barry Plant is based at the Cork University hospital. He is an internationally recognized expert in adult CF including clinical care, clinical trials and investigator initiated studies.
He was the coordinator of the EU funded consortium CFMATTERS, which completed a randomised multi-centre control trial of microbiome-derived antimicrobial treatments versus current empirical therapy. Recently Barry was a Global PI on a triple therapy CFTR modulator in CF.

Nominations
Application
CV

Isabelle Fajac, FR
Jane Davies, UK – ending first mandate
Pavel Drevinek, CZ – ending first mandate
Trudy Havermans, BE
Barry Plant, IE – ending first mandate
Dorota Sands, PL
Carsten Schwarz, DE
Isabelle Sermet, FR